These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 15265241)

  • 1. Hospitalization rates among patients with community-acquired pneumonia treated with telithromycin vs clarithromycin: results from two randomized, double-blind, clinical trials.
    Niederman MS; Chang JR; Stewart J; Asche CV; Lavin B; Nusrat R; Sullivan SD
    Curr Med Res Opin; 2004 Jul; 20(7):969-80. PubMed ID: 15265241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of hospitalization rates in patients with community-acquired pneumonia treated with telithromycin for 5 or 7 days or clarithromycin for 10 days.
    Tellier G; Chang JR; Asche CV; Lavin B; Stewart J; Sullivan SD
    Curr Med Res Opin; 2004 May; 20(5):739-47. PubMed ID: 15140341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of hospitalization rates in patients with community-acquired pneumonia treated with 10 days of telithromycin or clarithromycin.
    Niederman MS; Chang JR; Stewart J; Nusrat R; Nieman RB
    Curr Med Res Opin; 2004 May; 20(5):749-56. PubMed ID: 15140342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and bacteriological efficacy and safety of 5 and 7 day regimens of telithromycin once daily compared with a 10 day regimen of clarithromycin twice daily in patients with mild to moderate community-acquired pneumonia.
    Tellier G; Niederman MS; Nusrat R; Patel M; Lavin B
    J Antimicrob Chemother; 2004 Aug; 54(2):515-23. PubMed ID: 15269191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of once-daily oral telithromycin compared with clarithromycin for the treatment of community-acquired pneumonia in adults.
    Mathers Dunbar L; Hassman J; Tellier G
    Clin Ther; 2004 Jan; 26(1):48-62. PubMed ID: 14996517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five-day telithromycin once daily is as effective as 10-day clarithromycin twice daily for the treatment of acute exacerbations of chronic bronchitis and is associated with reduced health-care resource utilization.
    Fogarty C; de Wet R; Mandell L; Chang J; Rangaraju M; Nusrat R
    Chest; 2005 Oct; 128(4):1980-8. PubMed ID: 16236845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacoeconomic analysis of community-acquired pneumonia treatment with telithromycin or clarithromycin].
    Rubio-Terrés C; Cots JM; Domínguez-Gil A; Herreras A; Sánchez Gascón F; Chang J; Trilla A
    Rev Esp Quimioter; 2003 Sep; 16(3):295-303. PubMed ID: 14702121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telithromycin versus clarithromycin for the treatment of community-acquired respiratory tract infections: a meta-analysis of randomized controlled trials.
    Li XM; Wang FC; Yang F; Jin YH
    Chin Med J (Engl); 2013; 126(11):2179-85. PubMed ID: 23769580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of 5-day, once-daily telithromycin compared with 10-day, twice-daily clarithromycin for the treatment of group A beta-hemolytic streptococcal tonsillitis/pharyngitis: a multicenter, randomized, double-blind, parallel-group study.
    Quinn J; Ruoff GE; Ziter PS
    Clin Ther; 2003 Feb; 25(2):422-43. PubMed ID: 12749505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerability of once-daily telithromycin compared with high-dose amoxicillin for treatment of community-acquired pneumonia.
    Hagberg L; Torres A; van Rensburg D; Leroy B; Rangaraju M; Ruuth E
    Infection; 2002 Dec; 30(6):378-86. PubMed ID: 12478329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and bacteriologic efficacy of telithromycin in patients with bacteremic community-acquired pneumonia.
    Carbon C; van Rensburg D; Hagberg L; Fogarty C; Tellier G; Rangaraju M; Nusrat R
    Respir Med; 2006 Apr; 100(4):577-85. PubMed ID: 16376537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telithromycin in the treatment of community-acquired pneumonia: a pooled analysis.
    Hagberg L; Carbon C; van Rensburg DJ; Fogarty C; Dunbar L; Pullman J
    Respir Med; 2003 Jun; 97(6):625-33. PubMed ID: 12814146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of 5-day therapy with telithromycin, a novel ketolide antibacterial, for the treatment of tonsillopharyngitis.
    Norrby SR; Quinn J; Rangaraju M; Leroy B
    Clin Microbiol Infect; 2004 Jul; 10(7):615-23. PubMed ID: 15214873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.
    Ye X; Sikirica V; Schein JR; Grant R; Zarotsky V; Doshi D; Benson CJ; Riedel AA
    Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of telithromycin in community-acquired pneumonia caused by pneumococci with reduced susceptibility to penicillin and/or erythromycin.
    van Rensburg DJ; Fogarty C; Kohno S; Dunbar L; Rangaraju M; Nusrat R
    Chemotherapy; 2005 Jul; 51(4):186-92. PubMed ID: 15980629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of telithromycin 800 mg once daily for 7 days in community-acquired pneumonia: an open-label, multicenter study.
    Fogarty CM; Patel TC; Dunbar LM; Leroy BP
    BMC Infect Dis; 2005 May; 5():43. PubMed ID: 15927060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telithromycin in the treatment of pneumococcal community-acquired respiratory tract infections: a review.
    Fogarty CM; Buchanan P; Aubier M; Baz M; van Rensburg D; Rangaraju M; Nusrat R
    Int J Infect Dis; 2006 Mar; 10(2):136-47. PubMed ID: 16183318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telithromycin.
    Wellington K; Noble S
    Drugs; 2004; 64(15):1683-94; discussion 1695-6. PubMed ID: 15257629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of telithromycin in community-acquired pneumonia.
    Van Rensburg DJ; Matthews PA; Leroy B
    Curr Med Res Opin; 2002; 18(7):397-400. PubMed ID: 12487505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telithromycin 800 mg once daily for seven to ten days is an effective and well-tolerated treatment for community-acquired pneumonia.
    Carbon C; Moola S; Velancsics I; Leroy B; Rangaraju M; Decosta P
    Clin Microbiol Infect; 2003 Jul; 9(7):691-703. PubMed ID: 12925111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.